Uptrend Under Pressure 100
Institutional selling is building — 7 distribution days in the last 25 sessions. Severe risk · 100/100 · 7 distribution days (SPY) Oct 26 Full briefing →
View
Simple research view

BMY · Bristol-Myers Squibb Company

$61.61 +0.21% Oct 26 close
Detected setup Record Volume · Setup Score 55/100

Stand aside — setup invalidated

Setup score 55, but distribution days reach 5 or more — stand aside until the condition resets.

Ask about BMY

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$BMY

Bristol-Myers Squibb Company

Bristol-Myers Squibb Company is a large-cap Pharmaceuticals: Major company in the Health Technology sector with a market cap of $126B.

Health Technology Pharmaceuticals: Major stock Stage 2 · Advancing Base 2
$61.61 latest close
Market Structure
Trend structure: downtrend
Latest event: bos (bearish)
Support 60.25–60.80 · 5 touches · strong
Support 56.78–57.22 · 4 touches · moderate
Resistance 62.05–62.29 · 4 touches · moderate
Support 54.80–55.04 · 3 touches · moderate
Support 57.60–57.81 · 3 touches · moderate
Historical record

No active setup in the latest scan — this page shows the last detection Legend AI made for $BMY. Every level, score and criterion below is computed from the Oct 26 close session (latest session), and may no longer hold.

Historical verdict · setup score 55/100 · data Oct 26 close · latest session

Stand aside — setup invalidated

Setup score 55, but distribution days reach 5 or more — stand aside until the condition resets.

Recent price action · daily
$60.00$65.00$70.00AugSepOct$61.61

What would change this verdict

What needs to turn for this to become buyable — the top failing checks across the legend council:

  • Minervini 1.5 Price > 50-day MA — Price $61.61 vs MA50 $63.15
  • Minervini 1.8 RS rank ≥ 70 (prefer ≥ 85) — RS rank 61
  • O'Neil L: RS rank ≥ 80 (IBD leadership) — RS rank 61
  • O'Neil M: Market in confirmed uptrend — Market phase: uptrend_under_pressure
  • Weinstein Stage 2 (Advancing phase) confirmed — Stage 3 (Topping)
  • Weinstein Volume expansion above average — Volume ratio 0.70x
Minority view — the council disagrees here
  • Minervini: avoid Trend-template read: fails Price > 50-day MA.
  • O'Neil: avoid CANSLIM read: fails L: RS rank ≥ 80 (IBD leadership).
  • Weinstein: avoid Stage-analysis read: topping (Stage 3) is not an advancing Stage 2.
50 Neutral
Legend Score · rates the stock Neutral (50/100) — held back by eps growth

Our proprietary 0-100 rating — the answer to Wall Street's black-box scores. Five pillars, each computed from real scan data, each explained below in plain English.

  • Relative Strength (25%) 61
  • Trend Template (25%) 75
  • Institutional Footprint (20%) 35
  • EPS Growth (15%) 30
  • Quality (SMR-like) (15%) 33

RS rank 61: above-average strength. Trend template 6/8: passes the uptrend screen, structure intact. Institutional score 35: mild distribution — sellers active. EPS up +0% — growing, but below the 25% leadership bar. Quality 33: weak fundamentals (sales growth 30, return on equity 42, leverage 20). Updated 2026-10-22.

Earnings

Pre-earnings setup

Next earnings Thursday, October 29, 2026 Before market open Exact clock time not supplied by source

Deterministic evidence

BMY+0.21%
Sector proxy · XLV+0.00%
Broad market · SPY+0.71%
Same completed session window ending 2026-10-26. BMY was +0.21 points vs XLV. -0.50 points vs SPY.
CatalystPending Stock reactionPositive Sector reactionWeak Opening surgePending Event riskEarnings-driven

Session internals Mixed

Rule: direction and internals disagree — it met neither the strong nor the weak rule. Judged on internals, not on the size of the move.

Vs prior close+0.21% From the open+0.36% Range position52% GapNo gap
QQQ confirmationConfirming (+1.11%) SMH confirmationConfirming (+2.74%)
Short-term conviction -1 points.
  • A sourced earnings report is still pending inside the risk window; ordinary technical conviction is reduced until it is out.
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $61.61 +0.2% Oct 26 close
52W High $68.64 10.2% below high
Wks Since High 9w
Base Depth 18.2%
RS Rank 22 percentile of scan
SMA 50 $63.15
Avg Vol 11,235,195
Rel Vol (Oct 26) 0.70× 0.64× on up days
More stats
52W Low $42.52
Tight Wks 0 1 today
Base B2
SMA 200 $59.84
RS Line vs High -16.4%
RS Line Slope -1.4% ▼
Group Rank #12/66
ADR% 2.8%
ATR(14) $1.97 (3.2%)
Vol Pace (live) N/A
A/D Days 14A / 12D
A/D Rating B
VDU Bars 0/10 d
Earnings in 2d
Position in 52-week range 73rdpercentile of the 52-week range
$42.52low
$68.64high

BMY Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for BMY.

Create Free Account

Technical Analysis Report Card

$BMY · $61.61 · as of 2026-10-26 · multi-factor read
56
/ 100
Technicals 56/100
Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating
Weekly ▬ Sideways / consolidating
Monthly ▬ Sideways / consolidating

Moving Averages

50-day$63.15 ↓
100-day$61.37 ↑
200-day$59.84 ↑
Bullish (50 > 200)

RSI (14)

Reading51.5 · Neutral

Neutral — momentum is balanced between buyers and sellers.

MACD (12/26/9)

StateImproving
Histogram+0.468

Improving — MACD crossed above its signal line but still below zero. Histogram contracting.

Bollinger Bands (20,2)

%B / Width69% · 11.3%

Mid-band — no directional band edge in play.

Volume · Buyer vs Seller

Up/Down vol0.64 · Distribution
Rel volume0.7×
Pocket pivots · 10d0
5d vs 50d vol97%
Heavy vol up / down0 / 2

Distribution — volume is concentrated on down days; sellers dominate. Recent volume is expanding versus its baseline.

  • 2 heavy-volume down days vs 0 up in the last 20 sessions — supply is showing.

Support & Resistance

R · $62.23swing level
R · $64.13swing level
R · $68.4152-week high
Price · $61.61now
S · $60.59swing level
S · $57.22swing level
S · $56.47swing level

Fibonacci · Uptrend swing

23.6%$65.05
38.2%$62.83
50.0% ◄ price here$61.04
61.8%$59.25
78.6%$56.69

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for BMY — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Above 200-day MA50/200 bullishVolume distribution
Want this read in a legend's voice? Ask a Legend about BMY
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
How to read the numbers: the setup score (55/100, in the verdict band) rates this trade setup. Each legend's A–D grade rates the same setup against that legend's own checklist — so a high score next to a C grade is not a contradiction. The setup can be strong without fitting that legend's style. When the council disagrees, the verdict band breaks the tie.

Council consensus: 5 of 9 legends are Watching — building, not yet a confirmed buy.
Minervini Avoid C Trend-template read: fails Price > 50-day MA.
Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $61.61, MA150 $60.27, MA200 $59.84
1.2 150-day MA > 200-day MAMA150 $60.27 vs MA200 $59.84
Failing evidence
1.5 Price > 50-day MAPrice $61.61 vs MA50 $63.15
1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 61
8/12 checks
O'Neil Avoid D CANSLIM read: fails L: RS rank ≥ 80 (IBD leadership).
Passing evidence
C: Quarterly EPS acceleration ≥ 25%+25.4% QoQ
A: Annual earnings & revenue qualityRev -0.2% | ROE 41.6%
Failing evidence
L: RS rank ≥ 80 (IBD leadership)RS rank 61
M: Market in confirmed uptrendMarket phase: uptrend_under_pressure
4/8 checks
Weinstein Avoid C Stage-analysis read: topping (Stage 3) is not an advancing Stage 2.
Passing evidence
Price above 30-week MA (200-day proxy)Price $61.61 vs MA200 $59.84
30-week MA trending upwardFrom weekly scan context
Failing evidence
Stage 2 (Advancing phase) confirmedStage 3 (Topping)
Volume expansion above averageVolume ratio 0.70x
4/7 checks
dennis Watch C Turtle read: no Donchian signal. The system stays flat until price takes out the 20-day high.
Passing evidence
No breakdown below the 20-day channel20-day low $56.15
Volatility-unit sizing (1N ≈ 1% of equity)1N = $1.72 (2.79% of price); the Turtles size 1 unit so a 1N move ≈ 1% of equity, making the 2N stop ≈ 2% equity risk
Failing evidence
S1: 20-day Donchian breakoutNot confirmed
S2: 55-day Donchian breakoutNot confirmed
5/7 checks
zanger Avoid C Zanger read: a hard gate is broken — either the pattern is not one of his six, or the entry is more than 5% past the breakout. He would not touch this.
Passing evidence
Not extended (≤5% above the breakout point)Measured as passing
Partial-profit plan: sell 20-30% at +15-20%Scale 20-30% at $70.85-$73.93; trail the rest
Failing evidence
Named Zanger pattern onlyRecord Volume is not one of Zanger's six
Breakout volume 1.5-2.0x averageData unavailable
4/6 checks
zweig Watch D Zweig read: part of his screen passes but not all: Insider buying; Price strength (RS ≥ 70) — wait for the full growth screen before treating this as a Zweig setup.
Passing evidence
EPS growth above the market (≥15% QoQ)+25.4% QoQ — Zweig wants growth above the S&P average
Reasonable price for the growth (P/E ≤ 35)Trailing P/E 17.8x — no PEG or forward P/E stored
Failing evidence
Insider buyingNo insider buying flagged
Price strength (RS ≥ 70)RS score 61 — Zweig buys strength, not bargains
4/8 checks
Livermore Watch B Pivotal-point read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$61.61
Distance from 52-week high10.2% below high
Failing evidence
Relative strengthRS 61
Volume vs average0.70x
3/6 checks
Darvas Watch B Box-theory read: constructive evidence is present, but relative strength is unresolved.

partialConsolidating within the box (11.0% from 52W high) — patience until it approaches the prior high.

Passing evidence
Price$61.61
Distance from 52-week high10.2% below high
Failing evidence
Relative strengthRS 61
Volume vs average0.70x
3/6 checks
Wyckoff Watch B Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.

mediumSign of Strength — breakout above trading range on expanding volume. Accumulation phase complete, markup beginning. RS 61.

Passing evidence
Price$61.61
Distance from 52-week high10.2% below high
Failing evidence
Relative strengthRS 61
Volume vs average0.70x
3/6 checks
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▼ Falling
127RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +1 B
A: 13 D: 12 Net: +165 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini’s published criteria · 5/7 met
B 5/7 criteria
Separate score from the Minervini Trend Template (6/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
✓ EPS acceleration ≥25% QoQ +25%
✗ Revenue growth ≥20% YoY -0%
✓ Gross margin ≥30% 54%
✓ ROE ≥17% 42%
✗ RS rating ≥80 (leadership) 61
✓ Stage 2 uptrend (Weinstein) Stage 2
✓ Within 25% of 52W high -10.2%

Method Playbook

Trade it like Wyckoff EXACT LEVELS · PRO
Wyckoff B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use the Spring/test, Sign of Strength, creek, or Last Point of Support boundary identified by the active structure.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a completed test or Sign of Strength/Last Point of Support confirmation with improving demand versus supply.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Start below the Spring/test low or structural support whose failure would invalidate the accumulation read.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Raise protection beneath successive Last Points of Support or meaningful higher lows during markup; never loosen it.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit on a failed Sign of Strength, support loss, or clear supply-dominant reversal such as an upthrust failure.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

Pattern Analysis (historical)

Record Volume ⚠ Weinstein Stage 3 (topping) ⚠ Not actionable yet
55 setup score
RS Score 61
Trend template 6/8
CANSLIM 66.5* (B)
cadence: daily lookback bars: 260 detector version: record_volume/2026-09-27 record bar ago: 7 record volume: 22566452 volume multiple: 2.01 volume ratio: 2.009 rare tier: ✗ bars since bigger: 16 since date: 2026-09-18 callout text: Highest daily volume since 2026-09-18 up day: ✗ absorbed: ✓ low held: ✗ day gain pct: -4.27 depth pct: 4.27 day range pct: 6.98 geometry: {'record_bar': {'bar': 252, 'bars_ago': 7, 'price': 57.58, 'date': '2026-10-12'}, 'record_volume': 22566452, 'callout_text': 'Highest daily volume since 2026-09-18', 'arrow_target': {'bar': 252, 'bars_ago': 7, 'price': 57.58, 'date': '2026-10-12'}} confidence kind: heuristic_match findings: ['Highest daily volume since 2026-09-18: 22,566,452 shares (2.0x the trailing average)', 'Price action constructive — down day fully absorbed since (record bar $60.15 -> $57.58, now $61.12)'] validation reason: valid generic setup multi tf evaluated: ✓ multi tf reason: weekly: MA stabilizing or rising — accumulation context supported
Why This Setup? D+W Confluence
Record Volume · schematic

Highest daily volume since 2026-09-18 — 22,566,452 shares (2.0x average), 7 bars ago, and price action is constructive (down day fully absorbed since). Big volume with holding prices means institutions are involved. Research/educational only, not a buy/sell recommendation. | Moderate trend (6/8) | Good RS (61) | Moderate pattern (68%) | Readiness 62/100 (early) | CANSLIM 66.5 (B) | ⚠ Weinstein Stage 3 (topping); Not actionable yet

The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

2/7 universals met
  • A relative-strength leader — not met RS rank 22 — laggard
  • Clear of earnings — not met in 2 days — event risk
  • Asymmetric reward — partly met Partly met — levels are a Pro detail
  • Not chasing (in range) — partly met Partly met — levels are a Pro detail
  • Volume confirms — partly met 0.8× average — light
  • In a confirmed uptrend — met Stage 2 · Trend template 6/8
  • Risk is defined — met Met — levels are a Pro detail
Why these seven? → The Universal Edge

Minervini Trend Template

6/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $61.61 vs SMA150 $60.27 / SMA200 $59.84
SMA 150 above SMA 200 SMA150 $60.27 vs SMA200 $59.84
SMA 200 trending up Slope +0.64 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $63.15
Price above SMA 50 $61.61 vs SMA50 $63.15
30%+ above 52-week low +44.9% from $42.52
Within 25% of 52-week high -10.2% from $68.64
RS score above 70 RS 61

Fundamentals

52W Range
73%
Mkt Cap SEC
125.9B
EPS QoQ
+25%
Rev YoY
-0%
ROE
42%
Gross Margin
54%
D/E
2.44
EPS TTM
$3.46
P/E TTM
17.8x
Float
2.0B
Insider
No Buy

Company

Company profile
Bristol-Myers Squibb Company
BMY · NYSE · Health Technology · Pharmaceuticals: Major
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
B 66.5* CANSLIM * disqualified on M
C · Curr. EPS
93
A · Annual EPS
84
N · New Highs
40
S · Supply/Demand
55
L · Leader RS
61
I · Inst. Spons.
96
M · Market
30

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
5/8
W. RS
58
W. Support
$53.44
W. Resist
$68.64
W. Patterns
Cup & Handle
Weekly Structure

Scan History

Aug 10: 79 (Trend Only)Aug 10: 80 (Trend Only)Aug 11: 79 (Trend Only)Sep 16: 55 (Wyckoff SOS)Oct 22: 55 (Record Volume)55
Oct 22
Record Volume
55
Sep 16
Wyckoff SOS ✓ Gate
55 -3.1%
Aug 11
Trend Only ✓ Gate
79 -3.1%
Aug 10
Trend Only ✓ Gate
80 -5.0%
Aug 10
Trend Only ✓ Gate
79 -5.0%

Latest News

Headlines for BMY
Loading headlines…

Get the full picture on BMY

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial